GO:0045087 innate immune response: Defense Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045087 innate immune response is defined as defense responses mediated by germline-encoded components that directly recognize components of potential pathogens.
• It is a biological_process that operates within minutes to hours of infection and is distinct from adaptive immunity.
• Major signaling axes include cGAS-STING sensing of cytosolic DNA, RIG-I/MDA5 sensing of RNA, and TLR/NF-kB and inflammasome pathways.
• Dysregulated innate immunity drives autoinflammation, cytokine storms, and tumor immune evasion, making it a therapeutic target.
• CRISPR knockout, knock-in, and overexpression cell models are essential to dissect causal genes in this pathway.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate innate immunity research.
Description
The innate immune response (GO:0045087) is the first line of host defense against pathogens, mediated by germline-encoded receptors that directly recognize conserved microbial components. Unlike adaptive immunity, it responds rapidly and lacks memory, but it is critical for initiating inflammation and shaping subsequent adaptive responses. This Gene Ontology term encompasses all biological processes by which innate immune cells and non-immune cells detect and respond to bacteria, viruses, fungi, and parasites. Understanding GO:0045087 is fundamental for researchers studying infection, autoimmunity, cancer, and gene therapy, because many disease mechanisms converge on innate immune signaling. For example, mitochondrial DNA released during cellular stress triggers cGAS-STING-dependent innate immune responses that contribute to inflammatory diseases. Similarly, innate immune responses to viral vectors can limit the efficacy of gene therapy, highlighting the need to dissect these pathways genetically. This article provides a research-grade overview of the innate immune response, its core mechanisms, key genes, disease links, and CRISPR-based methods to study it.
innate immune response At A Glance
| GO ID | GO:0045087 |
|---|---|
| GO term | innate immune response |
| Ontology | biological_process |
| Synonym | innate immunity; nonspecific immune response |
| Major function | Direct recognition and defense against pathogens via germline-encoded receptors |
| Key pathways | cGAS-STING, RIG-I/MDA5, TLR/NF-kB, inflammasome |
| Cell types | Macrophages, dendritic cells, neutrophils, epithelial cells |
| Disease relevance | Autoinflammation, cytokine storm, cancer, gene therapy complications |
What Is GO:0045087?
According to the Gene Ontology, GO:0045087 innate immune response is defined as defense responses mediated by germline-encoded components that directly recognize components of potential pathogens. This definition emphasizes that the recognition machinery is inherited rather than somatically rearranged, and that it targets molecular patterns shared by pathogens. The term is a biological_process and includes signaling cascades, cytokine production, phagocytosis, and antimicrobial effector mechanisms.
Why Is innate immune response Important in Cell Biology?
GO:0045087 is important because it governs the earliest host-pathogen interactions and determines the outcome of infections, inflammatory diseases, and cancer immunotherapy. Dysregulation of innate immunity can cause severe pathology, such as cytokine storms in SARS-CoV-2 infection or autoinflammatory syndromes driven by mitochondrial DNA release. Moreover, innate immune responses to viral vectors pose a major barrier to gene therapy, making this pathway a key consideration in therapeutic design.
• Provides rapid first-line defense against bacteria, viruses, fungi, and helminths.
• Initiates and shapes adaptive immune responses through cytokine and antigen presentation.
• Dysregulation causes autoinflammatory and autoimmune diseases.
• Contributes to cytokine storm in severe viral infections like COVID-19.
• Limits efficacy of gene therapy vectors such as AAV.
• Plays dual roles in cancer: antitumor immunity versus tumor-promoting inflammation.
• Serves as a target for vaccine adjuvants and immunotherapies.
• Essential for understanding host-pathogen evolution and emerging infectious diseases.
• Involved in neuroinflammation and neurodegeneration.
• Offers opportunities for CRISPR-based functional genomics.
What Happens During innate immune response?
Pathogen Recognition by Germline-Encoded Receptors
In simple terms: The body has fixed sensors that spot common molecules on germs.
Innate immune responses begin when germline-encoded pattern recognition receptors (PRRs) detect pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). These receptors include Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), NOD-like receptors (NLRs), and cytosolic DNA sensors such as cGAS. Recognition is immediate and non-specific, allowing rapid response to a broad range of pathogens.
Signal Transduction and Transcription Factor Activation
In simple terms: Sensors trigger a chain reaction that turns on immune genes.
Upon ligand binding, PRRs activate downstream adaptors such as MyD88, TRIF, MAVS, and STING, leading to phosphorylation of IRF3/7 and NF-kB. These transcription factors translocate to the nucleus and induce type I interferons, pro-inflammatory cytokines, and chemokines. This signaling cascade is tightly regulated to avoid excessive inflammation.
Inflammasome Activation and Cytokine Maturation
In simple terms: A molecular platform activates powerful inflammatory cytokines.
Cytosolic sensors such as NLRP3 assemble inflammasomes, which activate caspase-1 to cleave pro-IL-1beta and pro-IL-18 into active cytokines. Pyroptosis, a form of inflammatory cell death, can also be triggered, releasing DAMPs that amplify the response. Inflammasome dysregulation is linked to autoinflammatory diseases.
Effector Mechanisms: Phagocytosis, Killing, and Interferon Response
In simple terms: Immune cells eat and destroy pathogens, and interferons make cells resistant to viruses.
Activated innate immune cells perform phagocytosis, produce reactive oxygen species, and release antimicrobial peptides. Type I interferons induce hundreds of interferon-stimulated genes that inhibit viral replication. These effector mechanisms collectively clear pathogens and limit infection spread.
Resolution and Transition to Adaptive Immunity
In simple terms: The initial response winds down and calls in the specific immune system.
After pathogen clearance, anti-inflammatory signals promote resolution to restore tissue homeostasis. Innate immune cells then present antigens and provide costimulation to activate T and B cells, bridging to adaptive immunity. This transition is critical for long-lasting protection.
Key Genes Involved in GO:0045087 innate immune response
The following genes encode core components of the innate immune response and are frequently studied using CRISPR models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CGAS | Cytosolic DNA sensor | Target for autoinflammation and cancer immunotherapy |
| STING1 | Adaptor for cytosolic DNA sensing | Mutations cause STING-associated vasculopathy |
| MAVS | Mitochondrial antiviral signaling adaptor | Central to RIG-I/MDA5 signaling |
| MYD88 | TLR/IL-1R signaling adaptor | Key for bacterial and viral sensing |
| TRIF | TLR3/TLR4 signaling adaptor | Mediates MyD88-independent TLR signaling |
| IRF3 | Transcription factor for type I IFN | Essential for antiviral response |
| IRF7 | Master regulator of type I IFN | Amplifies interferon production |
| NFKB1 | Transcription factor for inflammation | Central to cytokine induction |
| NLRP3 | Inflammasome sensor | Driver of autoinflammatory diseases |
| CASP1 | Inflammasome effector protease | Cleaves IL-1beta and IL-18 |
| IL1B | Pro-inflammatory cytokine | Mediator of fever and inflammation |
| IL18 | Pro-inflammatory cytokine | Enhances NK and T cell responses |
| IFNB1 | Type I interferon | Antiviral and immunomodulatory |
| IFIH1 | MDA5, cytosolic RNA sensor | Mutations linked to type 1 diabetes |
| DDX58 | RIG-I, cytosolic RNA sensor | Detects short viral RNA |
| TBK1 | Kinase activating IRF3/7 | Target for antiviral and cancer therapy |
| IKBKB | IKK-beta kinase | Activates NF-kB |
How Is innate immune response Regulated?
The innate immune response is tightly regulated at multiple levels to prevent excessive inflammation. Negative regulators include A20 (TNFAIP3), SOCS proteins, and deubiquitinases that terminate signaling. Post-translational modifications such as ubiquitination and phosphorylation control the stability and activity of key adaptors like STING and MAVS. Additionally, mitochondrial dynamics and DNA release are regulated by autophagy and mitophagy, which limit cGAS-STING activation. Dysregulation of these checkpoints contributes to autoinflammatory and autoimmune diseases.
innate immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STING1 | STING-associated vasculopathy | Knock-in of gain-of-function mutation in THP-1 cells |
| NLRP3 | Cryopyrin-associated periodic syndromes | Knock-in of disease mutation in iPSC-derived macrophages |
| CGAS | Autoinflammation, cancer immunity | Knockout in primary macrophages |
| IFIH1 | Type 1 diabetes, antiviral defense | Point mutation knock-in in HEK293T |
| MAVS | Antiviral signaling deficiency | Knockout in A549 cells |
Autoinflammatory and Autoimmune Diseases
Gain-of-function mutations in innate immune sensors or adaptors cause autoinflammatory syndromes. For example, activating mutations in STING1 lead to STING-associated vasculopathy with onset in infancy, characterized by systemic inflammation. Similarly, NLRP3 gain-of-function mutations cause cryopyrin-associated periodic syndromes. Mitochondrial DNA release can trigger cGAS-STING-dependent inflammation in various autoimmune conditions.
Viral Infections and Cytokine Storm
Excessive innate immune activation contributes to severe viral diseases. In SARS-CoV-2 infection, dysregulated pulmonary innate immune responses drive cytokine storm and acute respiratory distress syndrome. Zika virus infection also triggers innate immune responses that can lead to neuroinflammation and congenital syndromes. Understanding these pathways is critical for developing host-directed therapies.
Cancer: Dual Roles of Innate Immunity
Innate immune responses can either promote antitumor immunity or support tumor progression. cGAS-STING activation enhances dendritic cell cross-presentation and T cell priming, favoring tumor control. However, chronic inflammation can create an immunosuppressive microenvironment that fosters tumor growth. Targeting innate immune pathways is therefore a promising but context-dependent therapeutic strategy.
Gene Therapy Complications
Innate immune responses to viral vectors such as AAV limit gene therapy efficacy and cause toxicity. Pre-existing immunity and vector-induced type I interferon responses can lead to clearance of transduced cells. Modulating innate immunity is a key goal in gene therapy design.
From innate immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive type I IFN production? | Knockout in THP-1 or primary macrophages |
| Does a disease-associated SNP alter signaling? | Point mutation knock-in in HEK293T or iPSCs |
| Can a reporter track NF-kB activation? | Knock-in of luciferase or fluorescent reporter |
| Does overexpression mimic chronic inflammation? | Overexpression in A549 or RAW264.7 cells |
| Which genes are essential for inflammasome assembly? | CRISPR library screening in macrophages |
| How does a pathogen evade innate immunity? | Knockout of sensing pathway in epithelial cells |
How to Study the innate immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify interferon-stimulated genes |
| Proteomics | Protein abundance and modifications | Map signaling complexes |
| Phosphoproteomics | Kinase activity | Dissect TLR/RLR cascades |
| Luciferase reporter | NF-kB/IRF activation | Validate CRISPR knockouts |
| Immunofluorescence | Protein localization | Assess STING trafficking |
| CRISPR screen | Gene essentiality | Discover novel innate immune regulators |
| ELISA | Cytokine secretion | Measure IL-6, TNF-alpha, IFN-beta |
Transcriptomic Profiling (RNA-seq)
RNA sequencing measures global gene expression changes upon innate immune activation, revealing interferon-stimulated genes and inflammatory signatures. It is widely used to identify pathways altered by CRISPR knockout of candidate genes.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications in innate immune signaling. Phosphoproteomics can map kinase cascades downstream of PRRs.
Imaging and Reporter Assays
Fluorescence microscopy and luciferase reporters visualize NF-kB or IRF activation in live cells. These methods are useful for validating signaling defects in CRISPR models.
Functional Genomics Screens
CRISPR knockout or activation screens identify novel regulators of innate immunity. Pooled screens coupled with next-generation sequencing enable unbiased discovery of pathway components.
How CRISPR Can Be Used to Study GO:0045087 innate immune response
Knockout
CRISPR knockout generates loss-of-function alleles to test whether a gene is required for innate immune responses. For example, knocking out CGAS or STING1 abolishes cytosolic DNA sensing. Knockout models are essential for causal inference in pathway dissection.
Point Mutation
CRISPR point mutation introduces specific disease-associated variants to study their functional impact. This is particularly useful for gain-of-function mutations in NLRP3 or STING1. Point mutation models help link genotype to inflammatory phenotypes.
Knock-in
Knock-in of reporter genes or epitope tags allows real-time tracking of innate immune proteins. Tagged knock-in of STING or MAVS enables localization and interaction studies. Knock-in models are also used to humanize mouse genes for drug testing.
Overexpression
Overexpression of wild-type or mutant innate immune genes can mimic chronic activation or rescue loss-of-function phenotypes. It is commonly used in HEK293T or A549 cells to study signaling. Overexpression must be interpreted cautiously due to non-physiological levels.
How EDITGENE Supports innate immune response Research
Researchers studying innate immune response-related genes often need to determine whether a candidate gene is causally involved in pathogen sensing, cytokine production, or inflammatory disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of innate immunity targets.
Contact EDITGENE today to design your custom CRISPR model for innate immune response research.
Frequently Asked Questions About innate immune response
What is GO:0045087 innate immune response?
GO:0045087 is a Gene Ontology biological process term defined as defense responses mediated by germline-encoded components that directly recognize components of potential pathogens.
What genes are involved in innate immune response?
Key genes include CGAS, STING1, MAVS, MYD88, TRIF, IRF3, IRF7, NFKB1, NLRP3, CASP1, IL1B, IL18, IFNB1, IFIH1, DDX58, TBK1, and IKBKB.
How does the innate immune response recognize pathogens?
It uses germline-encoded pattern recognition receptors such as TLRs, RLRs, NLRs, and cGAS to detect PAMPs and DAMPs.
What is the role of cGAS-STING in innate immunity?
cGAS senses cytosolic DNA and activates STING, leading to IRF3 and NF-kB activation and type I interferon production.
How is innate immunity different from adaptive immunity?
Innate immunity is rapid, non-specific, and lacks memory, while adaptive immunity is slower, specific, and generates immunological memory.
What diseases are linked to innate immune dysregulation?
Autoinflammatory syndromes, cytokine storms, autoimmune diseases, cancer, and gene therapy complications.
How can CRISPR be used to study innate immune response?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of genes in innate immune pathways.
What cell models are best for innate immunity research?
Macrophages (THP-1, RAW264.7), dendritic cells, epithelial cells (A549), and HEK293T are commonly used.
What is the role of inflammasomes in innate immunity?
Inflammasomes are cytosolic platforms that activate caspase-1, leading to IL-1beta/IL-18 maturation and pyroptosis.
How does innate immunity affect gene therapy?
Innate immune responses to viral vectors like AAV can limit transgene expression and cause toxicity.
Conclusion
The innate immune response (GO:0045087) is a cornerstone of host defense, mediated by germline-encoded sensors that detect pathogens and initiate inflammation. Its dysregulation underlies a wide range of diseases, from autoinflammation to cancer and gene therapy complications. CRISPR-based cell models are indispensable for dissecting the causal roles of individual genes in this pathway. EDITGENE offers comprehensive CRISPR services to accelerate discovery in innate immunity research.
References
- 1. Hu MM et al.. 2023. Mitochondrial DNA-triggered innate immune response: mechanisms and diseases.. Cell Mol Immunol 20(12):1403-1412 PMID: 37932533
- 2. Català C et al.. 2022. Innate immune response to peritoneal bacterial infection.. Int Rev Cell Mol Biol 371:43-61 PMID: 35965000
- 3. Dauletbekov DL et al.. 2019. Innate Immune Response Following AAV Administration.. Adv Exp Med Biol 1185:165-168 PMID: 31884606
- 4. Rodrigues de Sousa J et al.. 2021. The innate immune response in Zika virus infection.. Rev Med Virol 31(2):e2166 PMID: 32926478
- 5. Wang Y et al.. 2023. Innate Immune Response to Viral Vectors in Gene Therapy.. Viruses 15(9) PMID: 37766208
- 6. Bottino E et al.. 2022. [Pulmonary innate immune response in Sars-cov-2 infection].. Rev Fac Cien Med Univ Nac Cordoba 79(1):33-42 PMID: 35312259
- 7. Yasmin H et al.. 2025. Innate Immune Response to Helminth Infections.. Adv Exp Med Biol 1476:251-273 PMID: 40622546
- 8. Li WS et al.. 2023. Innate immune response restarts adaptive immune response in tumors.. Front Immunol 14:1260705 PMID: 37781382
